The total patients treated with the following conditions:
· Wet age-related macular degeneration (AMD)
· Diabetic macular oedema (DMO)
· Macular oedema secondary to retinal vein occlusion, branch (branch RVO)
· Macular oedema secondary to retinal vein occlusion, central (central RVO)
· Myopic choroidal neovascularization (mCNV)
The volume of use of the following treatment options:
· Ranibizumab
· Bevacizamab
· Aflibercept
· Dexamethasone intravitreal implant
· Fluocinolone acetonide intravitreal implant
· Laser Therapy
I would like this information for the period March 2015 to February 2016, broken down by month
